To use Oracle BIEE, please enable javascript in your browser.
The number of individual cases identified in EudraVigilance for COVID-19 VACCINE JANSSEN (AD26.COV2.S) is 71,635 (up to 31/12/2023)

Number of individual cases by Age Group

 
 
 
 
Age Group
Cases
%
Not Specified 4,876 6.8%
0-1 Month 19 0.0%
2 Months - 2 Years 53 0.1%
3-11 Years 6 0.0%
12-17 Years 117 0.2%
18-64 Years 61,489 85.8%
65-85 Years 4,648 6.5%
More than 85 Years 427 0.6%
Total 71,635 100.0%

Number of individual cases by Sex

 
 
 
 
Sex
Cases
%
Female 37,925 52.9%
Male 30,925 43.2%
Not Specified 2,785 3.9%
Total 71,635 100.0%

Number of individual cases by Geographic Origin (EEA/Non-EEA)

 
 
 
 
Occurrence Country EEA/Non EEA
Cases
%
European Economic Area 59,360 82.9%
Non European Economic Area 12,275 17.1%
Not Specified 0  
Total 71,635 100.0%

Number of individual cases by Reporter Group

 
 
 
 
Reporter Group
Cases
%
Healthcare Professional 27,669 38.6%
Non Healthcare Professional 43,966 61.4%
Not Specified 0  
Total 71,635 100.0%
For the interpretation of the results, please refer to the key considerations at www.adrreports.eu